Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 41

2.

Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L; CLOSURE I Investigators.

N Engl J Med. 2012 Mar 15;366(11):991-9. doi: 10.1056/NEJMoa1009639.

3.

Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.

Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L; CLOSURE I Investigators.

Stroke. 2010 Dec;41(12):2872-83. doi: 10.1161/STROKEAHA.110.593376. Epub 2010 Nov 4.

4.

Stenting versus endarterectomy for treatment of carotid-artery stenosis.

Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators.

N Engl J Med. 2010 Jul 1;363(1):11-23. doi: 10.1056/NEJMoa0912321. Epub 2010 May 26. Erratum in: N Engl J Med. 2010 Jul 8;363(2):198. N Engl J Med. 2010 Jul 29;363(5):498.

5.

Atherosclerotic Peripheral Vascular Disease Symposium II: stroke intervention: state of the art.

Alberts MJ, Felberg RA, Guterman LR, Levine SR; American Heart Association Writing Group 4.

Circulation. 2008 Dec 16;118(25):2845-51. doi: 10.1161/CIRCULATIONAHA.108.191174. No abstract available. Erratum in: Circulation. 2009 Jun 30;119(25):e604.

6.

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group.

Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29. Erratum in: Lancet Neurol. 2008 Nov;7(11):985.

7.

Telmisartan to prevent recurrent stroke and cardiovascular events.

Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group.

N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.

8.

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group.

N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.

9.

Neuroprotection and the ischemic cascade.

Felberg RA, Burgin WS, Grotta JC.

CNS Spectr. 2000 Mar;5(3):52-8.

PMID:
18277329
11.

Cryptogenic stroke patients with patent foramen ovale should be closed only in the setting of a randomized control trial.

Felberg RA.

Catheter Cardiovasc Interv. 2007 Jan;69(1):4-5. No abstract available.

PMID:
17173277
12.

Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis.

Ramee SR, Subramanian R, Felberg RA, McKinley KL, Jenkins JS, Collins TJ, Dawson RC, White CJ.

Stroke. 2004 May;35(5):e109-11. Epub 2004 Apr 15.

13.
14.
15.

Carotid stents to prevent stroke: a nonsurgical option.

White CJ, Ramee SR, Collins TJ, Jenkins JS, Silva JA, Chan AW, Reily JP, Qunitana HA, Felberg RA, McKinley KL.

Ochsner J. 2003 Winter;5(1):18-23.

16.

Brain attack.

Felberg RA.

Ochsner J. 2003 Winter;5(1):44-6. No abstract available.

18.
19.

Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion.

Christou I, Felberg RA, Demchuk AM, Burgin WS, Malkoff M, Grotta JC, Alexandrov AV.

J Neuroimaging. 2002 Apr;12(2):119-23.

PMID:
11977905
20.

Cell death in experimental intracerebral hemorrhage: the "black hole" model of hemorrhagic damage.

Felberg RA, Grotta JC, Shirzadi AL, Strong R, Narayana P, Hill-Felberg SJ, Aronowski J.

Ann Neurol. 2002 Apr;51(4):517-24.

PMID:
11921058
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk